New Two-Pronged attack on rare head and neck cancer
Disease control
Recruiting now
This study is testing if combining a hormone-blocking therapy (androgen deprivation therapy) with an immunotherapy drug (pembrolizumab) can help control advanced salivary gland cancer. It is for adults whose cancer has spread or returned, cannot be treated with surgery or radiati…
Phase: PHASE2 • Sponsor: Manish Patel • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC